ID   DNCV_VIBCH              Reviewed;         436 AA.
AC   Q9KVG7;
DT   16-OCT-2013, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-JUL-2015, entry version 51.
DE   RecName: Full=Cyclic AMP-GMP synthase;
DE            Short=c-AMP-GMP synthase;
DE            EC=2.7.7.- {ECO:0000269|PubMed:22500802, ECO:0000269|PubMed:25131990};
DE   AltName: Full=Dinucleotide cyclase DncV;
GN   Name=dncV; OrderedLocusNames=VC_0179;
OS   Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Vibrionales;
OC   Vibrionaceae; Vibrio.
OX   NCBI_TaxID=243277;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 39315 / El Tor Inaba N16961;
RX   PubMed=10952301; DOI=10.1038/35020000;
RA   Heidelberg J.F., Eisen J.A., Nelson W.C., Clayton R.A., Gwinn M.L.,
RA   Dodson R.J., Haft D.H., Hickey E.K., Peterson J.D., Umayam L.A.,
RA   Gill S.R., Nelson K.E., Read T.D., Tettelin H., Richardson D.L.,
RA   Ermolaeva M.D., Vamathevan J.J., Bass S., Qin H., Dragoi I.,
RA   Sellers P., McDonald L.A., Utterback T.R., Fleischmann R.D.,
RA   Nierman W.C., White O., Salzberg S.L., Smith H.O., Colwell R.R.,
RA   Mekalanos J.J., Venter J.C., Fraser C.M.;
RT   "DNA sequence of both chromosomes of the cholera pathogen Vibrio
RT   cholerae.";
RL   Nature 406:477-483(2000).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE SPECIFICITY, GENE NAME,
RP   INDUCTION, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF 131-ASP--ASP-133.
RC   STRAIN=ATCC 55056 / El Tor Ogawa E7946, and El Tor C6706;
RX   PubMed=22500802; DOI=10.1016/j.cell.2012.01.053;
RA   Davies B.W., Bogard R.W., Young T.S., Mekalanos J.J.;
RT   "Coordinated regulation of accessory genetic elements produces cyclic
RT   di-nucleotides for V. cholerae virulence.";
RL   Cell 149:358-370(2012).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 3-413 IN COMPLEX WITH
RP   MAGNESIUM AND CYCLIC DINUCLEOTIDE, FUNCTION, CATALYTIC ACTIVITY,
RP   ENZYME REGULATION, COFACTOR, SUBUNIT, AND MUTAGENESIS OF GLN-112 AND
RP   ILE-257.
RX   PubMed=25131990; DOI=10.1016/j.cell.2014.07.028;
RA   Kranzusch P.J., Lee A.S., Wilson S.C., Solovykh M.S., Vance R.E.,
RA   Berger J.M., Doudna J.A.;
RT   "Structure-guided reprogramming of human cGAS dinucleotide linkage
RT   specificity.";
RL   Cell 158:1011-1021(2014).
CC   -!- FUNCTION: Catalyzes the synthesis of cyclic AMP-GMP from ATP and
CC       GTP. Is also able to produce c-di-AMP and c-di-GMP from ATP and
CC       GTP, respectively; however, c-AMP-GMP is the dominant molecule
CC       produced by DncV in vivo, contrary to the c-GMP-AMP produced by
CC       eukaryotes. Is required for efficient V.cholerae intestinal
CC       colonization, and down-regulates the colonization-influencing
CC       process of chemotaxis. Is not active with dATP, TTP, UTP, and CTP.
CC       {ECO:0000269|PubMed:22500802, ECO:0000269|PubMed:25131990}.
CC   -!- CATALYTIC ACTIVITY: ATP + GTP = 2 diphosphate + cyclic A-P(3'-
CC       5')G-P(3'-5'). {ECO:0000269|PubMed:22500802,
CC       ECO:0000269|PubMed:25131990}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:25131990};
CC       Note=Binds 1 Mg(2+) ion per subunit.
CC       {ECO:0000269|PubMed:25131990};
CC   -!- ENZYME REGULATION: Lacks a regulatory loop and is constitutively
CC       activated. {ECO:0000269|PubMed:25131990}.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:25131990}.
CC   -!- INDUCTION: Expression is repressed by the transcriptional
CC       regulator VspR. {ECO:0000269|PubMed:22500802}.
CC   -!- DISRUPTION PHENOTYPE: Cells lacking this gene show a significant
CC       defect in intestinal colonization. {ECO:0000269|PubMed:22500802}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AE003852; AAF93355.1; -; Genomic_DNA.
DR   PIR; F82354; F82354.
DR   RefSeq; NP_229836.1; NC_002505.1.
DR   RefSeq; WP_001901330.1; NC_002505.1.
DR   PDB; 4TXY; X-ray; 3.00 A; A/B=3-413.
DR   PDB; 4TXZ; X-ray; 2.80 A; A/B=3-413.
DR   PDB; 4TY0; X-ray; 1.80 A; A/B=3-413.
DR   PDB; 4U03; X-ray; 2.04 A; A/B=1-419.
DR   PDB; 4U0L; X-ray; 2.10 A; A/B=1-419.
DR   PDB; 4U0M; X-ray; 2.30 A; A/B=1-419.
DR   PDB; 4U0N; X-ray; 2.10 A; A/B=1-419.
DR   PDB; 4XJ1; X-ray; 1.77 A; A=1-215, A=242-412.
DR   PDB; 4XJ3; X-ray; 1.65 A; A=1-215, A=242-412.
DR   PDB; 4XJ4; X-ray; 1.60 A; A=1-215, A=242-412.
DR   PDB; 4XJ5; X-ray; 1.55 A; A=1-215, A=242-412.
DR   PDBsum; 4TXY; -.
DR   PDBsum; 4TXZ; -.
DR   PDBsum; 4TY0; -.
DR   PDBsum; 4U03; -.
DR   PDBsum; 4U0L; -.
DR   PDBsum; 4U0M; -.
DR   PDBsum; 4U0N; -.
DR   PDBsum; 4XJ1; -.
DR   PDBsum; 4XJ3; -.
DR   PDBsum; 4XJ4; -.
DR   PDBsum; 4XJ5; -.
DR   STRING; 243277.VC0179; -.
DR   DNASU; 2614190; -.
DR   EnsemblBacteria; AAF93355; AAF93355; VC_0179.
DR   GeneID; 2614190; -.
DR   KEGG; vch:VC0179; -.
DR   PATRIC; 20079408; VBIVibCho83274_0163.
DR   OMA; CIRIEIA; -.
DR   OrthoDB; EOG6ZPSW3; -.
DR   BioCyc; VCHO:VC0179-MONOMER; -.
DR   Proteomes; UP000000584; Chromosome 1.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0061501; F:cyclic-GMP-AMP synthase activity; IDA:UniProtKB.
DR   GO; GO:0052621; F:diguanylate cyclase activity; IDA:UniProtKB.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0009190; P:cyclic nucleotide biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0050922; P:negative regulation of chemotaxis; IDA:UniProtKB.
DR   GO; GO:0009405; P:pathogenesis; IMP:UniProtKB.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; GTP-binding; Magnesium;
KW   Metal-binding; Nucleotide-binding; Nucleotidyltransferase;
KW   Reference proteome; Transferase.
FT   CHAIN         1    436       Cyclic AMP-GMP synthase.
FT                                /FTId=PRO_0000423945.
FT   NP_BIND     112    117       GTP. {ECO:0000269|PubMed:25131990}.
FT   METAL       131    131       Magnesium; catalytic.
FT                                {ECO:0000269|PubMed:25131990}.
FT   METAL       133    133       Magnesium; catalytic.
FT                                {ECO:0000269|PubMed:25131990}.
FT   METAL       193    193       Magnesium; catalytic.
FT                                {ECO:0000269|PubMed:25131990}.
FT   BINDING     182    182       ATP. {ECO:0000269|PubMed:25131990}.
FT   BINDING     259    259       ATP. {ECO:0000269|PubMed:25131990}.
FT   BINDING     287    287       GTP. {ECO:0000269|PubMed:25131990}.
FT   BINDING     301    301       GTP. {ECO:0000269|PubMed:25131990}.
FT   BINDING     348    348       GTP. {ECO:0000269|PubMed:25131990}.
FT   MUTAGEN     112    112       Q->T: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:25131990}.
FT   MUTAGEN     131    133       DID->AIA: Loss of catalytic activity.
FT                                Lack of effect on chemotaxis.
FT                                {ECO:0000269|PubMed:22500802}.
FT   MUTAGEN     257    257       I->R: No effect on enzyme activity.
FT                                {ECO:0000269|PubMed:25131990}.
FT   STRAND        3      6       {ECO:0000244|PDB:4XJ5}.
FT   HELIX         8     12       {ECO:0000244|PDB:4XJ5}.
FT   TURN         14     16       {ECO:0000244|PDB:4XJ5}.
FT   HELIX        18     22       {ECO:0000244|PDB:4XJ5}.
FT   HELIX        26     59       {ECO:0000244|PDB:4XJ5}.
FT   HELIX        64     72       {ECO:0000244|PDB:4XJ5}.
FT   HELIX        75     78       {ECO:0000244|PDB:4XJ5}.
FT   HELIX        81     93       {ECO:0000244|PDB:4XJ5}.
FT   HELIX        96    103       {ECO:0000244|PDB:4XJ5}.
FT   STRAND      108    112       {ECO:0000244|PDB:4XJ5}.
FT   HELIX       113    115       {ECO:0000244|PDB:4XJ5}.
FT   TURN        116    118       {ECO:0000244|PDB:4XJ5}.
FT   STRAND      130    140       {ECO:0000244|PDB:4XJ5}.
FT   STRAND      144    146       {ECO:0000244|PDB:4XJ4}.
FT   HELIX       151    168       {ECO:0000244|PDB:4XJ5}.
FT   STRAND      172    176       {ECO:0000244|PDB:4XJ5}.
FT   STRAND      181    185       {ECO:0000244|PDB:4XJ5}.
FT   HELIX       186    188       {ECO:0000244|PDB:4XJ5}.
FT   STRAND      190    194       {ECO:0000244|PDB:4XJ5}.
FT   STRAND      196    200       {ECO:0000244|PDB:4XJ5}.
FT   HELIX       201    213       {ECO:0000244|PDB:4TY0}.
FT   HELIX       242    244       {ECO:0000244|PDB:4XJ5}.
FT   STRAND      246    248       {ECO:0000244|PDB:4XJ5}.
FT   STRAND      250    253       {ECO:0000244|PDB:4XJ5}.
FT   STRAND      255    258       {ECO:0000244|PDB:4XJ5}.
FT   HELIX       261    275       {ECO:0000244|PDB:4XJ5}.
FT   HELIX       278    293       {ECO:0000244|PDB:4XJ5}.
FT   HELIX       301    314       {ECO:0000244|PDB:4XJ5}.
FT   HELIX       322    338       {ECO:0000244|PDB:4XJ5}.
FT   HELIX       356    358       {ECO:0000244|PDB:4XJ5}.
FT   HELIX       361    381       {ECO:0000244|PDB:4XJ5}.
FT   HELIX       386    397       {ECO:0000244|PDB:4XJ5}.
FT   HELIX       404    406       {ECO:0000244|PDB:4XJ5}.
FT   STRAND      407    411       {ECO:0000244|PDB:4XJ5}.
SQ   SEQUENCE   436 AA;  49363 MW;  FB462969F3628BE6 CRC64;
     MRMTWNFHQY YTNRNDGLMG KLVLTDEEKN NLKALRKIIR LRTRDVFEEA KGIAKAVKKS
     ALTFEIIQEK VSTTQIKHLS DSEQREVAKL IYEMDDDARD EFLGLTPRFW TQGSFQYDTL
     NRPFQPGQEM DIDDGTYMPM PIFESEPKIG HSLLILLVDA SLKSLVAENH GWKFEAKQTC
     GRIKIEAEKT HIDVPMYAIP KDEFQKKQIA LEANRSFVKG AIFESYVADS ITDDSETYEL
     DSENVNLALR EGDRKWINSD PKIVEDWFND SCIRIGKHLR KVCRFMKAWR DAQWDVGGPS
     SISLMAATVN ILDSVAHDAS DLGETMKIIA KHLPSEFARG VESPDSTDEK PLFPPSYKHG
     PREMDIMSKL ERLPEILSSA ESADSKSEAL KKINMAFGNR VTNSELIVLA KALPAFAQEP
     SSASKPEKIS STMVSG
//
